Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 05 September, 2009 and appeared in  Issue 485Cardiovascular HealthObesity

Key protein Links Obesity, Diabetes and Heart Disease

Researchers say they know why obesity leads to diabetes and cardiovascular disease, a finding that may help experts target therapies to limit the health impact of being very overweight.  
Advertisement

Yuichi Oike of Kumamoto University in Japan states that a protein that causes ongoing, low-grade inflammation within fat tissues, also contributes to the health consequences that come with obesity.   

The culprit Oike's team identifies is a fat-derived protein called angiopoietin-like protein 2, or Angptl2. In mice, Angptl2 levels are elevated in fat tissue. Those levels increase even more in the oxygen-deprived conditions typically found within obese fat tissue.  

Higher Angptl2 levels are also found in the blood of people with higher body mass index and insulin levels.  

Obese mice lacking Angptl2 show less inflammation in their fat tissue and are less insulin resistant, the researchers report. Likewise, otherwise healthy mice made to have higher than normal Angptl2 levels in their fat tissue develop inflammation and insulin resistance.

Angptl2 starts an inflammatory cascade, causing blood vessels to remodel and attracting immune cells called macrophages, they note.  

The researchers concluded that Angptl2 is a new molecular target that could be used to improve the diagnosis and treatment of obesity and related metabolic diseases.

Cell Press, news release, Sept. 1, 2009

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 September, 2009 and appeared in  Issue 485Cardiovascular HealthObesity

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control